Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
acute, AEs, anniversary, APP, AUC, billion, bioprinting, biweekly, BLA, blocker, blood, BLQ, brokering, calm, Capricor, celebrate, certified, Cmax, Colorado, Connecticut, contagion, Ctrough, dataset, Deposit, dexterity, dialogue, disadvantaged, disallowed, divergent, downturn, Dyne, Edgewise, elevate, Entrada, Epic, EUDAMED, excitotoxicity, faster, fifteen, folding, fulfill, GGL, Glaxo, GlaxoSmithKline, GSK, GST, Haldol, haloperidol, harnessed, holiday, homologue, infection, Inland, installment, intermolecular, intracerebroventricular, invasion, IRA, ischemia, IVDR, lag, macroeconomic, matured, maturity, MedTech, micromolar, microphysiological, mild, moderate, Monian, multidose, multifaceted, MZ, negligible, neurodegeneration, neurofilament, neuropathology, NfL, nonhuman, NY, overexpression, Parliament, patchwork, pharmacovigilance, phenotype, phenylbutyrate, postnatal, predominantly, prepayment, PRISMTM, quantification, RA, rationale, reassure, receivership, relyvrio, remarkably, remeasured, RNAscope, sector, sexual, SHIELD, shortage, silico, Silicon, Silvergate, siRNA, skeletal, sodium, spleen, striatal, Suisse, swept, syndicate, taurursodiol, thrive, Tiapridal, tiapride, Transposon, Ukraine, unitary, unutilized, Utah, Valley, versatile, veteran, Virginia, warrant, weak, white, wider, YAC, York, ZZ
Removed:
activation, adolescence, aimed, Analyst, ASO, ASU, Azevan, BDNF, birth, Brown, characterizing, codon, communicating, complement, degenerative, dispense, educate, engine, gradual, handicapped, hearing, intention, interpreted, intravitreal, investigating, Jr, knocking, locked, magnitude, Matthew, microRNA, misfold, murine, NaN, NeuBase, neurology, neurotrophic, NHP, nM, nominate, nominated, nomination, ophthalmology, Oxford, participated, photoreceptor, pigmentosa, posterior, precedent, privately, productivity, proportional, radioactive, recessive, reliable, Relief, retinal, rho, rhodopsin, Robert, rod, satisfying, signaling, Simplifying, slightly, slower, suggesting, suited, suppression, suspended, syndrome, synthetically, traditionally, transport, Trump, Usher, usherin, Wood
Filing tables
Filing exhibits
Related press release
Associated WVE transcripts
WVE similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-208598, 333-221480, 333-228308, 333-233054, 333-234519, 333-243491, 333-243515, 333-259196, 333-260948, and 333-268286) on Form S-8 and (Nos. 333-233052 and 333-263251) on Form S-3, of our report dated March 23, 2023, with respect to the consolidated financial statements of Wave Life Sciences Ltd. and subsidiaries.
/s/ KPMG LLP
Boston, Massachusetts
March 23, 2023